Mandate

VINGE ADVISES SWEGON

July 10, 2014

Vinge has advised Swegon in connection with the acquisition of 90 per cent of the shares in the Belgian airflow technology company P. Lemmens from the current shareholders Waterland Private Equity and Stephan Lemmens. P. Lemmens has 59 employees and had a turnover of EUR 26 million in 2013. P. Lemmens largest product segment is total airflow control within an integrated electronic control system. The other product segments include fans, ventilation and heat recovery products.

Swegon is part of the Latour Group and is a market leading producer and supplier of energy efficient ventilation and climate systems. Swegon has 1 650 employees and a turnover of SEK 3.3 billion.

Vinge’s team consisted of partner Magnus Pauli and associate Daniel Lennartsson.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026